Graham Faces Tough Agenda In Science Post

WASHINGTON-William Graham, confirmed Oct. 1 as presidential science adviser and director of the White House Office of Science and Technology Policy, faces a scientific community skeptical of his ability to affect science policy but hopeful he can represent their interests before the administration. He assumed office in the White House the following day shortly after 3 p.m. The voice vote in the Senate ended a nine-month search for a successor to George Keyworth II, who left the administration J


Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

WASHINGTON-William Graham, confirmed Oct. 1 as presidential science adviser and director of the White House Office of Science and Technology Policy, faces a scientific community skeptical of his ability to affect science policy but hopeful he can represent their interests before the administration.

He assumed office in the White House the following day shortly after 3 p.m. The voice vote in the Senate ended a nine-month search for a successor to George Keyworth II, who left the administration Jan. 1 to form a consulting company. John McTague and Richard Johnson served successively as acting directors in the interim.

Graham, 49, is an electrical engineer from southern California who was named deputy administrator of the National Aeronautics and Space Administration six weeks before the Challenger accident in January. He served as acting administrator until James Fletcher was appointed last spring.

"He took steps to restore stability to this agency in very ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
3D illustration of a gold lipid nanoparticle with pink nucleic acid inside of it. Purple and teal spikes stick out from the lipid bilayer representing polyethylene glycol.
February 2025, Issue 1

A Nanoparticle Delivery System for Gene Therapy

A reimagined lipid vehicle for nucleic acids could overcome the limitations of current vectors.

View this Issue
Considerations for Cell-Based Assays in Immuno-Oncology Research

Considerations for Cell-Based Assays in Immuno-Oncology Research

Lonza
An illustration of animal and tree silhouettes.

From Water Bears to Grizzly Bears: Unusual Animal Models

Taconic Biosciences
Sex Differences in Neurological Research

Sex Differences in Neurological Research

bit.bio logo
New Frontiers in Vaccine Development

New Frontiers in Vaccine Development

Sino

Products

Tecan Logo

Tecan introduces Veya: bringing digital, scalable automation to labs worldwide

Explore a Concise Guide to Optimizing Viral Transduction

A Visual Guide to Lentiviral Gene Delivery

Takara Bio
Inventia Life Science

Inventia Life Science Launches RASTRUM™ Allegro to Revolutionize High-Throughput 3D Cell Culture for Drug Discovery and Disease Research

An illustration of differently shaped viruses.

Detecting Novel Viruses Using a Comprehensive Enrichment Panel

Twist Bio